Viropro, ProteoCell Biotechnologies Sign Collaboration Agreement

Viropro Pharma Inc., a subsidiary of Viropro Inc., and ProteoCell Biotechnologies Inc. have signed a collaboration agreement to co-commercialize specific recombinant biogeneric biotherapeutics for international markets. Specializing in the commercialization of biopharmaceutical products, Viropro Pharma previously acquired licenses from Tokyo-based ImmunoJapan Inc. (IJI) for patented protein production technologies related to specific therapeutics.

Yahoo News (http://biz.yahoo.com/pz/050315/74481.html)